diksha3847's blog

Market Scenario

The global small animal imaging market is expected to gain prominence over the forecast period (2018–2027). It is estimated that the global small animal imaging market is expected to grow at a CAGR ~ 6.5 % during the forecast period of 2018–2027.

Small Animal Imaging Market is a process employed using imaging devices and reagents for monitoring the molecular or cellular process for biochemical, biological, diagnostic or therapeutic application in animals such as rats and mice for drug development and gene expression studies. Moreover, the small imaging systems are the cost-effective method for regular validation and commercialization of new drugs as it includes the whole body scan of the animals.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6175

The market growth is driven by the increasing demand for non-invasive small animal imaging techniques and technological advancements in the field of small animal imaging techniques. Furthermore, prominent market players are focused on continuous launches of product which is likely to contribute to the market growth. For instance, in September 2016, Aspect Imaging introduced M-series of compact MR imaging systems for pre-clinical research along with new integrated simultaneous PET-MRI systems.

However, stringent government regulations regarding animal usage in experiments and the high cost of devices may restrain the growth of global small animal imaging market.

Segmentation

The global small animal imaging market is segmented on the basis of the modality and reagents.

On the basis of the modality, the market is classified into optical imaging systems, nuclear imaging systems, micro-MRI systems, micro-ultrasound systems, micro-CT systems, photoacoustic imaging systems, and Magnetic Particle Imaging (MPI) systems. The optical imaging systems are further segmented into bioluminescence/ fluorescence imaging systems, standalone fluorescence imaging systems, and optical + X-Ray/optical + CT systems. The nuclear imaging systems are segmented into micro-Pet systems, micro-spect systems, and trimodality (spect/pet/CT) systems. The micro-pet system is further segmented into standalone pet systems, pet/CT system, and pet/MRI systems. The micro-spect system is further segmented into standalone spect systems, spect/CT system, and spect/MRI systems.

On the basis of reagent, the market is segmented as optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. The optical imaging reagents are further segmented as bioluminescent imaging reagents and fluorescent imaging reagents. The bioluminescent imaging reagents are further segmented into luciferins, pro-luciferins, coelenterazine, and other bioluminescent imaging reagents. The fluorescent imaging reagents are further segmented as green fluorescent proteins, red fluorescent proteins, infrared dyes, other fluorescent imaging reagents. The nuclear imaging reagents are segmented into pet tracers and spect probes. The pet tracers are further classified into fluorine-18-based small animal pet tracers, carbon-11-based small animal pet tracers, copper-64-based small animal pet tracers, and other spect probes. The spect probes are further segmented into technetium-99m-based small animal spect probes, iodine-131-based small animal spect probes, gallium-67-based small animal spect probes, thallium-201-based small animal spect probes, and other spect probes. The MRI contrast agents are segmented into gadolinium-based small animal contrast agents, iron-based small animal contrast agents, and manganese-based small animal contrast agents. The CT contrast agents are further segmented into iodine-based small animal CT contrast agents, barium-based small animal CT contrast agents, gold nanoparticles and gastrografin-based small animal CT contrast media.

Regional Analysis:

Geographically, the market has been segmented into America, Europe, Asia Pacific, and the Middle East & Africa. The Americas small animal imaging market is further segmented into North America, and South America. North America is further classified as U.S. and Canada.

The Europe small animal imaging market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, U.K., Italy, Spain, and the Rest of Western Europe. 

The Asia Pacific small animal imaging market is segmented into Japan, China, India, Republic of Korea, Australia, and the Rest of Asia Pacific.

The Middle East & Africa small animal imaging market is segmented into the Middle East and Africa.

Get Full Report at https://www.marketresearchfuture.com/reports/small-animal-imaging-market-6175

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Embolic Protection Devices Market Information: By type (Distal Filter Devices, Proximal Occlusion Devices), Material (Nitinol), Usage (Disposable Devices), Application (Cardiovascular Diseases), End-User (Hospitals & Clinics) – Global Forecast Till 2027

Market Highlights

Embolic protection devices are devices used to prevent or reduce plaque debris from reaching the distal bed during surgical procedures. They are commonly used in Saphenous Vein Graft (SVG) interventions and during carotid artery stenting procedures.

Global Embolic Protection Devices Market is expected to grow at a CAGR of 8.5% during the forecast period.

Get Sample Report at https://www.marketresearchfuture.com/sample_request/5978

Key Players  

Some of the key players in the Embolic Protection Devices Market are Medtronic, Abbott, Boston Scientific, Cordis. Contego Medical, W. L. Gore & Associates, Claret Medical, Allium Medical Solutions, and Angioslide.

Segmentation

The global embolic protection devices market is segmented on the basis of type, material, usage, application, and end-user.

On the basis of type, the market is segmented into distal filter devices, distal occlusion devices, and proximal occlusion devices.

On the basis of material, the market is segmented into nitinol and polyurethane.

On the basis of usage, the market is segmented into disposable devices and reusable devices.

On the basis of application, the market is segmented into cardiovascular diseases, neurovascular diseases, and peripheral vascular diseases. On the basis of cardiovascular diseases, it is further sub-segmented into coronary artery diseases, trans Cather aortic valve replacement, and saphenous vein graft diseases.

On the basis of the end-user, the market is segmented into hospitals and clinics, specialty centers, and ambulatory surgical centers.

Regional Analysis

The Americas dominates the global embolic protection devices market owing to the increasing aging population, which eventually leads to the increasing patient population. Additionally, the increasing cardiovascular disorder rates are likely to enhance the growth of embolic protection devices in the North American region. According to the American Heart Association, 31% of the deaths in the U.S. were due to cardiovascular disorders. Similarly, according to the Center for Disease Control and Prevention, in 2015, around USD 3.2 trillion were spend in healthcare expenditure in the U.S.

Europe accounts for the second largest market due to the increasing cardiovascular disorders and increasing obesity rates. Additionally, the increasing government support and increasing healthcare infrastructure along with the rising demand for minimally invasive treatment are driving the growth of the embolic protection devices market in Europe. For instance, Eurostat estimated that over 19.2% of the population in Europe were aged 65 and above. This rising older population is likely to lead to the increased patient population. These factors are likely to drive the growth of the embolic protection devices market.

Access Report @ https://www.marketresearchfuture.com/reports/embolic-protection-devices-market-5978

Asia Pacific is the fastest growing market for the embolic protection devices whose growth is attributed to rising population and increasing standard of living. Additionally, increasing healthcare spending and rising demand for new and innovative treatment options are likely to drive the growth of the market. India and China are the major contributors to the market growth due to the rapid development of healthcare infrastructure in these regions and increasing demand for diagnostic services.

On the other hand, the Middle East and Africa is expected to witness a slow growth due to limited access to healthcare and affordability issues among the population. In the Middle East, the growth of the market is driven by the increasing availability of new and advanced diagnostic and treatment methods for various chronic diseases.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Surgical Lights Market: Information By Type (Surgical Lights (Ceiling Mounted, Mobile Surgical Lights, Surgical Headlights, Wall Mounted), Examination Lights (General Exam Light, Endoscope Light Vein Light, Medical Pen Light)), By Technology (Light Emitting Diode, Halogen Lights), By Application (Surgical Suites, Endoscopy Procedures, Dental Procedures, Others) and End-User (Hospital Operating Rooms, Ambulatory Surgical Centers, Procedure Rooms) - Forecast till 2027

Segment Analysis

The Global Surgical Lights Market has been segmented on the basis of Type, Technology, Application, and End User. The market, based on type, has been segmented into surgical lights and examination lights. The market, based on surgical lights, has been further segmented into ceiling mounted, mobile surgical lights, surgical headlights, and wall-mounted. The market, based on examination lights, has been further segmented into general exam light, endoscope light vein light, and medical penlight. The market, on the basis of technology, has been divided into LED and halogen. The global surgical lights market, based on application, has been segmented into surgical suites, endoscopy procedures, and dental procedures. The global surgical lights market, by end-user, has been categorized as hospital operating rooms, ambulatory surgical centers, procedure rooms.

Get Sample Report at https://www.marketresearchfuture.com/sample_request/5803

Key Players

Market Research Future (MRFR) recognizes KONINKLIJKE PHILIPS N.V. (Netherlands), A-dec Inc. (US), CV Medical (US), Herbert Waldmann GmbH & Co. KG (Germany), STERIS plc (Ireland), Hill-Rom Services Inc. (US), Integra LifeSciences Corporation (Israel), S.I.M.E.O.N. Medical GmbH & Co. KG (Germany), Getinge AB (Sweden), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Skytron, LLC (US), Stryker (US), Technomed India (India), Sunnex Group (Sweden), and BihlerMED (US), as the Key Players in the Global Surgical Lights Market.

Market Highlights

Global Surgical Lights Market estimated to be valued at USD 929.43 Million by 2025 and is expected to register a CAGR of 5.30% during the forecast period.

The surgical light market is growing at a very steady pace. Some of the factors that are pushing the growth of the market are high adoption of the LED technology in medical lighting, advancements in hospital operating rooms, an increase in the number of hybrid operation theatres (OTs) all across the world, and an increasing number of surgical procedures. The major players in the market are also involved in strategic ventures to capture maximum market space. For instance, in April 2019, Integra LifeSciences introduced new Codman specialty surgical products, including Integra Duo, LED surgical headlight. With the addition of this product, the company aims to expand its product portfolio. Thus, such strategies followed by prominent players are expected to fuel the market growth during the assessment period.

Regional Analysis

Geographically, the global surgical lights market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. As per MRFR analysis, the Americas was the largest market for surgical lights in 2018 and is expected to remain dominant during the review period. The rising demand for high-quality surgical lighting systems, the development of new technologies for operating rooms, and the concentration of key players in the market are also boosting the market growth in the American region.

Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. An increasing number of specialty care services for various surgical procedures and increasing demand for technologically advanced healthcare solutions for diagnosis and treatment for diseases fuel the market growth.

The market in Asia-Pacific is expected to register a significant growth rate during the forecast period. The majority of the companies in Asia-Pacific are committed to investing in research and development of surgical light treatments which will ultimately boost the growth of the market. Also, the presence of major players in this region, such as Mitsubishi Electric Corporation (Japan), and Sumitomo Heavy Industries, Ltd (Japan), is contributing substantially to the growth of the surgical lights market in the Asian region.

Get Full Report at https://www.marketresearchfuture.com/reports/surgical-lights-market-5803

The Middle East and Africa surgical lights market is growing at a steady rate. Several companies are investing in the Middle Eastern and African countries to expand their position in the surgical lights market. For instance, In February 2017, S.I.M.E.O.N. Medical GmbH & Co. KG (Germany) founded the subsidiary S.I.M.E.O.N. Medical MEA SAL in Beirut, Lebanon, to meet the demands of a rapidly growing patient population in the Middle East.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Surgical Lights Market: Information By Type (Surgical Lights (Ceiling Mounted, Mobile Surgical Lights, Surgical Headlights, Wall Mounted), Examination Lights (General Exam Light, Endoscope Light Vein Light, Medical Pen Light)), By Technology (Light Emitting Diode, Halogen Lights), By Application (Surgical Suites, Endoscopy Procedures, Dental Procedures, Others) and End-User (Hospital Operating Rooms, Ambulatory Surgical Centers, Procedure Rooms) - Forecast till 2027

Segment Analysis

The Global Surgical Lights Market has been segmented on the basis of Type, Technology, Application, and End User. The market, based on type, has been segmented into surgical lights and examination lights. The market, based on surgical lights, has been further segmented into ceiling mounted, mobile surgical lights, surgical headlights, and wall-mounted. The market, based on examination lights, has been further segmented into general exam light, endoscope light vein light, and medical penlight. The market, on the basis of technology, has been divided into LED and halogen. The global surgical lights market, based on application, has been segmented into surgical suites, endoscopy procedures, and dental procedures. The global surgical lights market, by end-user, has been categorized as hospital operating rooms, ambulatory surgical centers, procedure rooms.

Get Sample Report at https://www.marketresearchfuture.com/sample_request/5803

Key Players

Market Research Future (MRFR) recognizes KONINKLIJKE PHILIPS N.V. (Netherlands), A-dec Inc. (US), CV Medical (US), Herbert Waldmann GmbH & Co. KG (Germany), STERIS plc (Ireland), Hill-Rom Services Inc. (US), Integra LifeSciences Corporation (Israel), S.I.M.E.O.N. Medical GmbH & Co. KG (Germany), Getinge AB (Sweden), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Skytron, LLC (US), Stryker (US), Technomed India (India), Sunnex Group (Sweden), and BihlerMED (US), as the Key Players in the Global Surgical Lights Market.

Market Highlights

Global Surgical Lights Market estimated to be valued at USD 929.43 Million by 2025 and is expected to register a CAGR of 5.30% during the forecast period.

The surgical light market is growing at a very steady pace. Some of the factors that are pushing the growth of the market are high adoption of the LED technology in medical lighting, advancements in hospital operating rooms, an increase in the number of hybrid operation theatres (OTs) all across the world, and an increasing number of surgical procedures. The major players in the market are also involved in strategic ventures to capture maximum market space. For instance, in April 2019, Integra LifeSciences introduced new Codman specialty surgical products, including Integra Duo, LED surgical headlight. With the addition of this product, the company aims to expand its product portfolio. Thus, such strategies followed by prominent players are expected to fuel the market growth during the assessment period.

Regional Analysis

Geographically, the global surgical lights market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. As per MRFR analysis, the Americas was the largest market for surgical lights in 2018 and is expected to remain dominant during the review period. The rising demand for high-quality surgical lighting systems, the development of new technologies for operating rooms, and the concentration of key players in the market are also boosting the market growth in the American region.

Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. An increasing number of specialty care services for various surgical procedures and increasing demand for technologically advanced healthcare solutions for diagnosis and treatment for diseases fuel the market growth.

The market in Asia-Pacific is expected to register a significant growth rate during the forecast period. The majority of the companies in Asia-Pacific are committed to investing in research and development of surgical light treatments which will ultimately boost the growth of the market. Also, the presence of major players in this region, such as Mitsubishi Electric Corporation (Japan), and Sumitomo Heavy Industries, Ltd (Japan), is contributing substantially to the growth of the surgical lights market in the Asian region.

Get Full Report at https://www.marketresearchfuture.com/reports/surgical-lights-market-5803

The Middle East and Africa surgical lights market is growing at a steady rate. Several companies are investing in the Middle Eastern and African countries to expand their position in the surgical lights market. For instance, In February 2017, S.I.M.E.O.N. Medical GmbH & Co. KG (Germany) founded the subsidiary S.I.M.E.O.N. Medical MEA SAL in Beirut, Lebanon, to meet the demands of a rapidly growing patient population in the Middle East.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Market Research Future adds the “Zika Virus Testing Market Report - Forecast Analysis Till 2027” report to their unique collection. Zika Virus Testing Market Research Report, By Types (Non-Integrated Implants, Integrated Implants), By Technology (Electronic and Mechanical) By End Users (Hospitals, Clinics And Others)- Global Forecast Till 2027

Division/Classification

The global industry is split on account of tests, end-users, and regions. The tests include serological/Zika virus antibody and molecular/nucleic acid amplification. Diagnostic units, hospitals, pathology labs, etc. form the end-users. By regions, the Zika virus testing market is divided on the basis of Asia Pacific, Europe, Americas, and the Middle East and Africa.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5662

Industry Study

Getting infected with the Zika virus results from mosquito bites. This makes Zika a mosquito-borne disease and is transmitted via the Aedes genus. Zika is transmitted akin to other mosquito-borne illnesses and can also be transferred from one person to another through sexual intercourse. An infected pregnant woman may also pass the virus to her unborn child.

Rising endeavors to contain the spread of this virus by the US FDA (United States Food and Drug Administration) are estimated to propel the market during 2017 to 2023 (forecast period). Moreover, initiatives taken by the US Department of Health & Human Services check the virus from infecting more people. These initiatives have also driven the need for Zika Virus Testing Market in the United States and other parts of the globe.

Back in August 2016, the FDA declared the testing of all donated blood products for Zika. This was done with the intention of preventing Zika spread through blood transfusion. The attempt paid off, with many people staying clear of the virus and keeping healthy. If this project was not undertaken, hundreds of people could have been contaminated with the virus.

Significant investments by the FDA and US government to introduce Zika testing in the hospitals and banks of the United States would also drive market sales in the near future. Moreover, attempts by vendors and producers to come up with Zika virus testing will assist the market in gaining more traction.

Most of the demand for these tests are predicted to stem from Florida. The city’s burgeoning Zika-affected population will contribute to the same. Wrong results from faulty diagnostic procedures and shortage of awareness across emerging nations can negatively impact the Zika virus testing market. 

Eminent Players and Industry Advancements

Prominent companies affiliated with the Zika virus testing market comprise Luminex Corporation, ARUP Laboratories, Roche Molecular Systems, Hologic, and Siemens Healthcare Diagnostics. To create efficient treatments and vaccines, advanced animal models are required. An improved comprehension of immunological protection correlates is also needed to protect ourselves from this disease.

Nowadays, the Zika virus is detected in view of clinical manifestations. Molecular detection and serological devices also play a major role. As the separation of this virus is difficult; LFAs, NASBA, and LAMP are used to detect the virus and ascertain the cause of the fever. These novel techniques have assisted in accurate & fast diagnosis. With the clinical symptoms of Zika not being pathognomic, the presence of this virus can be established only when it is separated and examined.

Few among many clinical symptoms of this disease are myalgia, headache, fever, maculopapular rashes, and arthralgia. Only upon further diagnosis and confirmation, are the treatments recommended to patients. Sometimes, similar symptoms can be mistaken for other illnesses. Thus, it’s best to go to the doctors and have it ruled in/out.            

Regional Overview    

The constant transmission of Zika in various American nations is reported to augment the need for testing services till 2023. Moreover, projects undertaken by the HHS, BARDA to boost diagnostic assay innovations for the identification and treatment of this illness could propel industry expansion over the forecast period.

Additionally, there is more outburst of the Zika virus across multiple Latin American nations. For instance, twenty one of the twenty six states in Brazil are affected by the Zika virus. Faster transmission in the world is projected to lead to the creation of more detection assays, thus steering the market incomes.       

Request Full Report @ https://www.marketresearchfuture.com/upcoming-reports/zika-virus-testing-market-5662

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Primary Aldosteronism Market research report, Type (type I, type II), Indication (heart attack, kidney failure, stroke), by Diagnosis (blood test, imaging), Treatment (surgery, aldosterone antagonists), End User (hospitals) - forecast till 2027

Market Highlights:

Increasing prevalence of primary aldosteronism, growing geriatric population, rising number of obese individuals in the developing as well as the developed regions and increasing consumption of alcohol are estimated to drive the market growth during the forecast period. Moreover, rising per capita healthcare expenditure boosts the growth of primary aldosteronism. However, lack of awareness and risks of excessive bleeding, infection, anesthesia reaction by the corrective surgeries will restrain the market growth during the projected period.

Get Sample Report at https://www.marketresearchfuture.com/sample_request/5522

Key Players:

The key players for the global primary aldosteronism market are Pfizer Inc. (U.S.), Sun Pharmaceutical Industries Ltd.  (India), Bristol Laboratories Ltd (England), CMP Pharma. (U.S.), Koninklijke Philips N.V. (The Netherlands), GE Healthcare (U.K), Siemens AG (Germany), Shimadzu Corporation (Japan), Canon Inc. (Japan), and others.

Segmentation:

The global Primary Aldosteronism Treatment Market is segmented on the basis of type, indications, diagnosis, treatment, and end users. On the basis of type, the market is segmented into Type I, and Type II. On the basis of indications, the market is categorised into heart attack, kidney failure, stroke, and others. On the basis of diagnosis, the market is segmented into blood test, imaging, and others. The blood test segment is sub-segmented into aldosterone profiling, renin profiling, and others. The imaging segment is sub-segmented into computed tomography (CT), positron emission tomography (PET), and others. On the basis of end users, the market is segmented into surgery, aldosterone antagonists, and others. The aldosterone antagonists is sub-segmented into spironolactone, eplerenone, and others.

Access Report Deatails @ https://www.marketresearchfuture.com/reports/primary-aldosteronism-market-5522

Regional Analysis:

America dominates the global primary aldosteronism market. Presence of a well-developed healthcare sector and huge patient population within the region enables the Americas to hold the largest share of the market. Moreover, changing lifestyle followed by the increasing healthcare expenditure boosts the market growth within the region. Europe is the second largest market for the primary aldosteronism. Factors such as availability of funds for research and huge patient population followed by government support for research & development drives the market within the region. Asia Pacific is the fastest growing region for the market. Presence of a huge patient population and continuously developing economies like India and China within the region enable the Asia Pacific region to be the fastest growing. However, the Middle East & Africa region has the least share in the global market. Presence of poor economies, stringent government policies, and lack of healthcare services especially within the African region restrains the market growth within the region.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Catheters Market Information, By Type (Cardiovascular Catheters, Specialty Catheters, Intravenous Catheters, Urinary Catheters, Neurological Catheters), By End Users (Hospitals & Clinics, Ambulatory Surgical Centers, and others)- Global Forecast till 2027

Key Players

Some of the major players in this market are Boston Scientific Corporation, Koninklijke Philips N.V, Abbott, Medtronic plc, B. Braun Melsungen AG, Becton, Dickinson and Company, Terumo Corporation, LuMend Corporation (US),  Covidien AG (Ireland), ACIST Medical Systems (US), and Cook Medical Inc. (US).

Get Sample Report at https://www.marketresearchfuture.com/sample_request/3186

Market Highlights

Catheters, a thin tube like medical devices inserted into a body cavity, duct, or vessel. They are used in drainage, administration of fluids or gases, and also to perform a wide variety of other tasks depending on the type of catheter. Increasing prevalence of the patients cardiac and urological diseases have increased the demand for the catheters. To increase the market demand, many manufacturers are trying to introduce the new and advanced types of catheters. The global catheter market is majorly driven by increasing prevalence of cardiac & urological diseases, increasing preference for minimal invasive therapy, and increasing geriatric population. Additionally, changing lifestyle and rising healthcare spending have spurred the growth of the market. However, long time for approval, and risk of infection may slow the growth of the market over the review period.

The global Catheters Market Insights Trends is expected to grow at a CAGR of 6.14% during the forecast period 2017-2023.

Segmentation

The global catheters market has been segmented on the basis of types and end users.

On the basis of the types, the market is segmented into cardiovascular catheters, specialty catheters, intravenous catheters, urinary catheters, neurological catheters, and others.

On the basis of the end users, the market is segmented into hospitals & clinics, ambulatory surgical centers, and others.

Regional Analysis

The Americas dominate the global market owing to a huge population with cardiac diseases, increasing geriatric population, strong government support for research & development and high health care spending. According to the WHO, in 2014, 9.7% of total America population had diabetes. Increasing prevalence of the diabetes has boosted the market growth in America. Additionally, changing lifestyle and the presence of major players in the market have fueled the growth of the market.

Europe is the second leading region in the global catheters market, which is followed by Asia Pacific. Asia Pacific is the fastest growing catheters market majorly driven by India, China, and Japan owing to a huge number of patients and rapidly growing economy. The healthcare expenditure in in Asia Pacific has increased during last few years, which has contributed to the growth of market.

The Middle East and Africa contribute the least to the growth of the global market. The UAE, Saudi Arabia, and Kuwait lead the Middle East & Africa market. Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition of the region. However, the growth of the African market is high due to the presence of opportunities for the development of the market.

Get Full Report at https://www.marketresearchfuture.com/reports/catheters-market-3186

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Medical Tourism Market Trends and Growth Research by Treatment Type (Orthopedic/Spine Treatments, Oncology/Cancer Treatments, Cosmetic Treatments, Cardiovascular Treatments, Dental Treatments, Fertility/IVF Treatments, others), by Regions - Global Forecast Till 2027

Key Players

Noted market players that are included in the report are Asklepios Kliniken Verwaltungsgesellschaft mbH, Shouldice Hospital, Bangkok Hospital, Bumrungrad International Hospital, Samitivej PCL, CHRISTUS MUGUERZA, Clemenceau Medical Center, Anadolu Medical Center, Prince Court Medical Centre, Fortis Healthcare, Gleneagles Global Hospitals Group, and Schoen-Kliniken. These market players are extensively profiled in MRFR's competitive analysis.

Get Sample Report at https://www.marketresearchfuture.com/sample_request/1975

Market Insights

Increasing costs of treatments for chronic diseases and other kinds of treatment have been highly encouraging of medical tourism. It has been a common practice in an effort to procure good treatment at lower costs. Developing economies around the world offer high-quality medical treatments which attract patients from other parts of the world. Market Research Future has published its newest report on the global Medical Tourism Market Forecast which reveals an expected and promising CAGR of  21.4% during the forecast period from 2017 to 2023. The market was found to be valued at USD 70,836.9 Mn at the start of the forecast period and is likely to grow to reach an impressive USD 226,762.7 Mn by the end of 2023.

In the US, an angioplasty treatment would cost well over USD 55,000. However, in India, the cost is a fraction of the price as USD 3,300. The drastic difference in costs has led patients in developed countries with high healthcare costs to seek treatment in countries which are emerging rapidly and have a similar medical infrastructure. The reduces waiting time for treatment in these countries is also a significant factor driving growth for the global market. Timely treatment is the key to speedy recovery. However, the prevalence of chronic diseases in some developed countries has resulted in waiting lists for treatments. These waiting lists can easily be skipped via medical tourism. Developing countries are positioning themselves as medical tourism hubs with plenty of support from local governments, thus increasing market growth. Investments in healthcare sectors of these countries have ensured high-quality treatments at comparatively low prices. Language barriers and long travel times are expected to work against market growth and challenge the global medical tourism market.

Latest Industry News

Abu Dhabi's Department of Culture and Tourism has just signed an MOU with the Medical Tourism Association to partner in its efforts to establish itself as a high-quality medical tourism destination

Cancun, Mexico, has begun development of "Health City" with the help of third-party The location of the project is situated 10 minutes from the airport and aims to increase medical tourism activities.

Market Segmentation

The global medical tourism market is segmented on the basis of type. This is divided into neurology/neurosurgery treatments, orthopedic/spine treatments, fertility/IVF treatments, cosmetic treatments, cardiovascular/cardiology treatments, oncology/cancer treatments, and dental treatments. Among these, The cosmetic treatments market is the most lucrative segment with a high demand for facial rejuvenation and breast reconstruction treatments. The cost-efficient prices at medical tourism destinations for cosmetic procedures drive the segment's growth.

Access Report @ https://www.marketresearchfuture.com/reports/medical-tourism-market-1975

Regional Analysis

The Asia Pacific, due to a high concentration of developing economies has a 43.7% share of the market making it the market leader by regional assessment. Investments in technological advancements and state of the art medical machinery are augmenting market growth. Moreover, The region includes South Korea which is a highly popular destination for cosmetic procedures. The APAC is expected to grow at a highly promising CAGR of 22% during the forecast period. Eastern and Central Europe also represent an important regional segment which is growing rapidly and is expected to establish itself as a medical tourism destination over the forecast period.

Segmentation:

The global needle biopsy market is segmented on the basis of type and applications. Based on type, the market has been segmented as fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy and image-guided biopsy. Based on the utility, the market has been segmented as disposable and reusable. Based on the applications, the market has been segmented as tumor, infection, inflammation and others.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Needle Biopsy Market Share, Growth And Trends Analysis By Type (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy) By Utility (Disposable, Reusable), By Applications (Tumor, Infection, Inflammation, Others) - Global Forecast Till 2027

Global Needle biopsy Market Players:

Key players profiled in the report are Boston Scientific Corporation, Cook Medical, CareFusion Corporation, Hologic, Inc., and Cardinal Health, Inc., Medax, C. R. Bard, Inc., Möller Medical GmbH, Becton, Dickinson and Company, Hakko co. ltd., Kompass, Argon Medical Devices, Inc. and others.

Test the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Needle biopsy Market” Research Report – Forecast till 2023

Get Sample Report at https://www.marketresearchfuture.com/sample_request/3830

Market Highlights

The Needle Biopsy Market Trends is chiefly driven by product development and the fall in prices of raw materials and components. The increasing cases of cancers and growing usage of biopsy needles is driving the market. Companies should focus on improving the distribution efficiency so as to reduce the pressures on prices due to huge market fragmentation. Distributional agreements between large players and advanced products such as multilayer needles will be extremely beneficial. The emergence of needle biopsy is estimated to pose the greatest threat to the biopsy needle market. Needle biopsy offers non-invasive diagnostic tests for detecting cancer as it used liquids such as blood, urine, saliva etc. to detect malignancy. Increasing automation will enhance the capabilities of needle biopsy and it may substitute the needle biopsy procedures. Real time progression of cancers is also possible in needle biopsy which raises the level of threat it possess to needle biopsy. The falling cost of products due to greater market fragmentation and the emergence of Chinese companies is expected to put additional pressures on prices.

In our estimates vacuum assisted needle biopsy will be the fastest growing segment. The increasing screening rates for cancers through the world will stimulate the market. Among the various cancers, breast cancer is expected to generate the largest use of needle biopsy. Needle Based Biopsy Guns is another lucrative strategy that is being pursued by many players. Core needle biopsy has a higher efficiency and detectability rate than fine needle aspiration biopsy. There is increasing bias to use core needle biopsy in combination with needle aspiration biopsy to achieve highest sensitivity and detectability. Thus, the two tests are complementary, and the effectiveness rate is highest with both tests are done together.

The growing stringent regulation and standards for medical devices, and the increasing uncertainty about reimbursement in the US are threatening the growth of the market.

Report Details @ https://www.marketresearchfuture.com/reports/needle-biopsy-market-3830

Segmentation:

The global needle biopsy market is segmented on the basis of type and applications. Based on type, the market has been segmented as fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy and image-guided biopsy. Based on the utility, the market has been segmented as disposable and reusable. Based on the applications, the market has been segmented as tumor, infection, inflammation and others.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Protein Therapeutics Market Research Report: By Type (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Others), By Application (Cancer, Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Others), By Protein Function (Enzymatic and Regulatory Activity, Special Targeting Activity, Vaccines, Others), By End User (Hospitals and Clinics, Specialty Centers, Others) – Forecast to 2027

Market Highlights

According to MRFR analysis, Global Protein Therapeutics Market Analysis Forecast is expected to register a 6.86% CAGR during the forecast period of 2020 to 2027. 

The rising prevalence of chronic diseases such as metabolic disorders, immunologic disorders, and hematological disorders is accountable for increasing the number of hospital admissions. Chronic disease prevalence is directly responsible for the growing demand for protein therapeutics, thus, driving the growth of this market. The increased awareness among consumers regarding the high efficiency of protein and the growing adoption of plasma-derived therapies are also driving the growth of the market during the forecast period. The plasma-derived therapy is widely used in the treatment of hemophilia and von Willebrand disease (VWD).

Get Sample Report at https://www.marketresearchfuture.com/sample_request/10142

The increasing prevalence of hemophilia is expected to drive the growth of the market. According to the report published by the National Hemophilia Foundation, more than 400,000 patients had hemophilia in 2018. Additionally, 1% of the US population was suffering from von Willebrand disease (VWD).

However, the high cost of protein therapies and unfavorable reimbursement are likely to curb the market growth during the forecast period.

Key Players

Some of the key players in the global protein therapeutics market are Abbott Laboratories (US), Amgen Inc. (US), Baxter International Inc. (US), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd. (Switzerland), Johnson & Johnson (US), Merck & Co., Inc. (US), Novo Nordisk A/S (Denmark), CSL Behring (US), Bristol Myers Squibb Co. (US), Pfizer Inc. (US), Sanofi (France), and Biogen, Inc. (US).

Segmentation

Global Protein Therapeutics Market has been segmented based on Type, Application, and End User.

The market, based on type, has been divided into monoclonal antibodies, insulin, fusion protein, erythropoietin, interferon, human growth hormone, follicle-stimulating hormone, and others. The insulin segment is the fastest-growing segment owing to the increasing prevalence of diabetes around the world. According to the report published by the International Diabetes Federation, around 463 million people have diabetes in the world, out of all, more than 59 million patients belong to the European region. Insulin is widely used in the management of Diabetes, which is projected to increase the demand for protein therapeutics during the forecast period.

On the basis of application, the global protein therapeutics market has been segregated into cancer, metabolic disorders, immunologic disorders, hematological disorders, and others. The cancer segment holds a significant share of the global protein therapeutics market owing to the rising prevalence of cancer across the globe. According to the National Cancer Institute, in 2020, it is estimated that there will be 21,750 new cases of ovarian cancer, and an estimated 13,940 people will die of this disease. It is likely to boost the growth of the market during the forecast period.

By End User, the global protein therapeutics market has been segmented into hospitals and clinics, specialty centers, and others. An increasing number of hospital admission and the rising prevalence of chronic diseases are expected to drive the growth of the hospitals and clinics segment during the forecast period.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas has been segmented into North America and Latin America, with the North American market being divided into the US and Canada. The Americas held the largest share in the global market in 2019. The presence of major market players and the increasing prevalence of immunologic disorders in the region are expected to boost market growth during the forecast period. 

The European market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. The protein therapeutics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the Rest of Asia-Pacific. Owing to the rising geriatric population and the presence of a large patient pool, the market in Asia-Pacific is expected to be the fastest-growing. The protein therapeutics market in the Middle East & Africa has been divided into the Middle East and Africa.

Access Report Details @ https://www.marketresearchfuture.com/reports/protein-therapeutics-market-10142

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Pages: 1 2 3 4 5 ... » »»